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Cooling towers are possible sources of contamination to the environment, with 
implications to human health. Cooling towers are known sources for disease outbreaks. The 
cooling process releases aerosols, which if cooling towers are not adequately sanitized, 
pathogenic bacteria may be released and contaminate the environment. Compounding the risk of 
pathogenic bacteria release, cooling towers provide ideal conditions for biofilms to grow which 
encourage the exchange of antibiotic resistance genes. Current sanitation methods are unable to 
prevent or effectively remove biofilms in cooling towers. Therefore, a new sanitation method is 
necessary. This research explores the feasibility of using electrical pulse generators (EPG) 
manufactured by Environmental Energy Technologies Inc. (EET) to disinfect cooling tower 
water. This sanitation method constantly lyses bacterial cells by sending pulsed electrical fields 
(PEF) through the water. EET has developed a standard EPG (STD EPG) that is currently in use 
and an experimental EPG (EXP EPG) that is a purportedly improved version of the STD EPG. 
The purpose of this study was to determine if the EXP EPG was more effective than the STD 
EPG to sanitize cooling towers through evaluating the microbial CFUs/ ml and diversity. Water 
samples from each EPG treatment were collected from several building installation on the 
Rochester Institute of Technology (RIT) campus. These were examined for microbial richness, 
diversity, antibiotic resistance, and identity using the 16S rRNA gene. The results of the study 
suggest that there is antibiotic resistant bacteria present in cooling towers. In addition to this 
seasonality impacted species diversity where the fall had a lower diversity than the summer. 
Finally, it was determined the two EPG treatments both able to effectively sanitized cooling 





Chapter 1: Introduction and Literature Review 
Introduction  
Cooling towers are possible sources of contamination to the environment, with 
implications to human health. Their purpose is to absorb and release heat from air conditioning, 
industrial, and power generation processes (Engelhart et al., 2008). They function in counter 
current systems where cool water from the cooling tower basin absorbs heat from heat 
exchangers. Then, the water is cooled through evaporative cooling and collects in the basin to b 
recirculated. However, when the water returns to the basin, it contains a higher concentration of 
inorganic and organic material (Kurtz et al., 1982). As a result, cooling towers create an 
environment where bacteria can thrive. Thriving bacterial communities can result in the 
development of biofilms, which are difficult to remove through current sanitation treatments 
(Ozdemir and Ceyhan, 2010). Biofilms are also able to resist antibiotics and increase the chance 
of genetic exchange of antibiotic resistance genes (Slonczewski and Foster, 2017; Balcázar et al., 
2015). Therefore, pathogens and antibiotic resistant bacteria may persist in cooling towers after 
sanitation treatments in biofilms, thus these bacteria can be released into the environment and 
cause contamination. Consequently, research addressing how to adequately disinfect cooling 
towers to prevent biofilm formation is an emerging field of study.  
Pulsed electrical fields (PEF) may be a superior method to disinfect cooling water as a 
preventative treatment that does not result in harmful byproducts or electro-resistance in the 
bacteria (Gusbeth et al., 2009). Therefore, I proposed to study the effectiveness of electronic 
pulse generators (EPG) manufactured by Environmental Energy Technologies Inc. (EET). EPG 
devices use a PEF to lyse bacterial cells, which reduces bacterial loads thus preventing biofilm 
production and scale accumulation within cooling towers. In this study, I evaluated the standard 
electronic pulse generator (STD EPG) that is currently used in the installations of EET and the 
experimental electronic pulse generator (EXP EPG) which is a modification of the STD EPG to 
be more efficient. Using water samples from each EPG treatment and examining microbial 
colony-forming units/ ml (CFU/ml), diversity, and antibiotic resistance, this study evaluates how 
effective these two EPG treatments are to sanitize cooling towers and prevent harmful bacteria 




Cooling Towers Function   
 Cooling towers are part of the heating, ventilation, and air conditioning (HVAC) systems 
in buildings. Their purpose is to cool and hold water that is used to dissipate heat from heat 
exchangers (Center for Disease Control, 2017). In the HVAC system, water from the cooling 
tower, in the cooled state, is pumped out to absorb heat from heat exchangers. Once the water 
has absorbed the heat, the water enters the top of the cooling tower to be cooled through 
evaporative cooling. The warmed water is sprayed from the top of the tower onto a surface, such 
as splash bars. Concurrently, atmospheric air interacts with the water and a fan blows air up and 
out of the tower to increase cooling (Figure 1). Evaporative cooling releases heat from the 
system and produces aerosols which are released into the environment through openings in the 
tower. Finally, the cooled water collects at the base of the cooling tower to be recirculated (Kurtz 
et al., 1982; Milosavljevic and Heikkilä, 2001). Although this process is effective in removing 
heat, it also causes serious sanitation and contamination concerns because if pathogenic bacteria 










Biofilms and Bacteria in Cooling Towers 
 Bacteria in cooling towers can persist in the water as planktonic or sessile organisms, 
however the majority are immobile bacteria in biofilm communities (Ozdemir and Ceyhan, 
2010). Biofilms are accumulations of microorganisms, established on a surface, surrounded by 
an extracellular matrix made up of polysaccharide polymers, DNA, proteins, and inorganic 
materials (Slonczewski and Foster 2017). These form where nutrients and conditions are ideal 
for growth because it is more efficient to be sessile than hunt for food (Slonczewski and Foster, 
2017). Cooling towers provide these conditions due to their large surface areas, low water flow 
speeds, and constant elevated temperature (Lin et al., 1998; Zacheus et al., 2000). The 
evaporative cooling process increases the concentration of organic and inorganic materials in 
water, which increases nutrients for bacteria, improving conditions for biofilm production (Kurtz 
et al., 1982). Additionally, construction materials of cooling towers may provide growth 
supporting factors. The leaching of biodegradable plasticizers can result in higher biomasses of 
biofilms (Colbourne, 1985). Consequently, these common cooling tower conditions provide 
habitat for bacteria to thrive and produce biofilms. 
Biofilm formation poses many threats to cooling towers, the most pressing to this 
research is their ability to be reservoirs of pathogens and resist removal through disinfection 
(Ozdemir and Ceyhan, 2010; Wingender and Flemming, 2011). The exopolysaccharides of the 
biofilm protect the bacteria from environmental conditions, antibiotics, and sanitation treatments 
(Ozdemir and Ceyhan, 2010; Slonczewski and Foster 2017). Biofilms are able to resist sanitation 
treatments, while the same planktonic cells cannot, due to the biofilm matrix which blocks the 
inner channels of the biofilm structure and protects the dense aggregates of bacteria within the 
biofilm (Ozdemir and Ceyhan, 2010). As a result, pathogenic bacteria can persist and even 
multiply in biofilms. Then, when conditions are no longer ideal the bacteria may be released 
from the biofilms and cause contamination to the cooling tower and subsequently the 
environment through the evaporative cooling emissions (Wingender and Flemming, 2011). 
Some known pathogens of concern in cooling towers are Legionella pneumophila and 
Pseudomonas aeruginosa. L. pneumophila is a pathogen of concern for cooling towers which 
causes Legionnaires Disease through inhaling the pathogen when aerosolized from the 




growth. The parasitized amoebae and biofilm act as a protective environment around L. 
pneumophila. It prevents L. pneumophila from being removed during sanitation treatments and 
allows it to survive in conditions that are not ideal for the pathogen (Kuiper et al., 2004; Kurtz et 
al., 1982; Yamamoto et al., 1992).  P. aeruginosa is also a bacteria of concern since it can 
synthesize biofilms in aquatic habitats, have amoebae associations, and produce biofilms in the 
lungs of cystic fibrosis patients which can lead to death (Branda et al., 2005; Brown and Barker, 
1999). In addition, Karami et al., (2020) found that biofilm formation of P. aeruginosa reduces 
its antibiotic susceptibility. These bacterial interactions with biofilms and their ability to form 
biofilms are an issue because although a sanitation treatment may be effective at removing 
planktonic cells, the bacteria in biofilms are protected and can remain in the system (Ozdemir 
and Ceyhan, 2010). Therefore, for sanitation treatments to be effective they must treat biofilms 
or prevent biofilms from forming. The EPG treatments use mechanisms to prevent biofilms from 
forming to avoid the issues biofilms cause.  
Antibiotic Resistance in Cooling Towers  
Biofilm formation not only resists disinfection but can increase the presence of antibiotic 
resistant bacteria. The bacteria grown in a biofilm state may not be antibiotic resistant 
genetically, but in this state the bacteria are less susceptible to the antibiotics (Anderl et al., 
2000). The biofilms may prevent antibiotics from affecting bacteria through several mechanisms. 
The polysaccharide matrix of the biofilm prevent antibiotics from penetrating into the biofilm to 
reach the bacteria, the bacterial cells may have a resistant phenotype, or the biofilm contains 
cells that are either slowly growing, not growing, or living in a stress response due to 
unfavorable conditions in the biofilm (Balcázar et al., 2015; Stewart, 2002; Stewart and 
Costerton, 2001; Slonczewski and Foster, 2017). These mechanisms are linked to the presence of 
antibiotic resistance genes (Anderl et al., 2000; Balcázar et al., 2015). Due to the close proximity 
of bacteria in biofilms there is an increased chance of genetic exchange of antibiotic resistance 
genes (Fux et al., 2005; Hausner and Wuertz, 1999; Li et al., 2002). Conjugation rates in biofilms 
are faster and larger biofilm surface/volume ratios are correlated with higher gene transfer 
efficiency (Hausner and Wuertz, 1999; Molin and Tolker-Nielsen, 2003). Consequently, since 




There is an enhanced risk to human health if there is a presence of antibiotic resistant pathogens 
in cooling towers due to their ability to share resistance genes and be dispersed into the 
environment as aerosols. 
There are many different antibiotic classes that use different mechanisms to treat bacterial 
infections. There are serious concerns for bacteria with multiple drug resistances. This study set 
out to evaluate if there were antibiotic resistant bacteria in the planktonic bacterial community of 
cooling towers, which could cause harm if released into the environment. The antibiotics in this 
study span a broad spectrum of the antibacterial classes. In addition, they are common drugs 
used in hospitals for bacterial infections (Coates et al., 2011; Whitburn, 2019). Therefore, 
resistance to these antibiotics would be concerning because of their wide use. 
Contamination to the Environment 
 The evaporative cooling process used by cooling towers to dissipate heat produces 
aerosols and releases them into the surrounding environment. This process can contaminate the 
environment when these aerosols contain pathogens or antibiotic resistant bacteria that were 
present in the cooling tower water. Legionnaires Disease caused by L. pneumophila are the most 
common illness borne from contaminated cooling towers. Outbreaks of this illness are well 
documented and were used as a case study to explain how far pathogens aerosolized from 
contaminated cooling towers can disperse disease. However this research did not focus on 
detecting L. pneumophila. In the largest L. pneumophila outbreak in 2001, a person passing 
through a 400 m radius of the contaminated cooling tower was very likely to contract 
Legionnaires Disease (García-fulgueiras et al., 2003). L. pneumophila outbreaks have been 
documented up to 3.4 km from contaminated cooling towers, indicating aerosolized pathogens 
were able to travel that far and still cause infection (Sala Ferré et al., 2009). These large zones of 
exposure put people who travel through them at severe risk of infection from pathogens cooling 
towers are contaminated with. Therefore, continuous sanitation of cooling towers is necessary to 




Current Sanitation Methods 
 According to Kurtz et al. (1982), sanitation methods should be effective in a vast range 
of pH and temperatures, be fast, and inexpensive. The current sanitation methods attempt to 
follow these guidelines, but other factors in cooling towers may influence them and render the 
sanitation ineffective. Chlorination is the most widely used method of sanitation, however it has 
limitations and drawbacks. High temperatures or pH, common conditions for cooling towers, 
render chlorination ineffective (Tchobanoglous and Burton, 2002). Chlorination also has harmful 
consequences such as corrosion of cooling tower infrastructure and interacting with organics 
resulting in halogenated organics and carcinogens (Emmanuel et al., 2004; Lin et al., 1998). 
Other sanitation methods are UV irradiation and ozone. Ozone is more often a supplemental 
treatment with another disinfectant due to its rapid decomposition (Muraca et al., 1987). UV 
irradiation requires a large UV light for the water to pass by. However, if the water is turbid light 
cannot penetrate the water deep enough to effectively sanitize (Schwartz et al., 2003). Silver-
copper ionization is a novel method of sanitation, which introduces electrically generated silver 
and copper ions into the water line to kill bacteria, specifically L. pneumophila (Lin et al., 1998). 
Unfortunately, an elevated pH can inactivate this method shifting the predominately positive 
copper ions to negative ions, preventing the ions from binding to the cells to lyse the cells (Lin et 
al., 2002). Consequently, all these sanitation methods are ineffective at consistently controlling 
bacterial growth within cooling towers and cannot prevent the accumulation and attachment of 
biofilms. 
Electronic Pulse Generator (EPG) 
 The drawbacks of these current sanitation methods make the novel use of EPGs an 
appealing solution (Figure 2). These function to reduce bacterial CFUs/ml in cooling tower 
waters and prevent biofilm accumulation by continually sanitizing the cooling towers with short 
electrical pulses. This method is based on electroporation which uses a low electrical field to 
form pores in the lipid bilayer. Conventionally, these pores are reversible, where the membrane 
can rebound around the cell and close up after the electrical field is removed (Joshi and 
Schoenbach, 2000). Conventional electroporation is used for transfection to insert DNA, 




and Hamilton, 1967; Weaver and Chizmadzhev, 1996). The EPG uses this same concept, but 
attempts to make a pore that results in cell lysis. It sends high voltage PEF through the water to 
create pores in the cell membrane. The pulses in the electrical field increases the probability of 
producing large pores or multiple pores that coalesce into large irreversible pores (Joshi and 
Schoenbach, 2002). Irreversible pores prevent the cell membrane from rebounding around the 
cell and cause cell lysis (Neumann and Rosenheck, 1972; Weaver and Chizmadzhev, 1996).  
 This novel sanitation method does not have the limitations of the current sanitation 
methods. Short electrical pulses have negligible thermal heating, low power inputs with large 
electrical fields, and time scales that can be adjusted for the pulse width. Additionally, multiple 
high-intensity pulses are able to cause more irreversible damage than single-shot electrical pulses 
(Joshi and Schoenbach, 2002). EPGs function to continually sanitizing the bulk water in the 
basin of cooling towers. This method of continually sanitizing water prevents bacteria from 
accumulating in the towers and developing biofilms. In comparison, the sanitation frequency for 
chlorination is anywhere from every 18 hours to several times a week (Tsao et al., 2019). EPGs 
are advantageous since they are unlikely to cause chemical modification of the water to change 
the genotoxicity. Comparatively, the chlorination disinfection method changes the chemical 
compounds to produce halogenated organic compounds (Emmanuel et al., 2004). Also, the 
survival of bacteria after this treatment is not due to electro tolerance transferred from bacterial 
descendants but rather an extreme bacteria feature. These features could be cell size, physiologic 
state of the microorganism, and cytoplasmic chemical content during the treatment (Gusbeth et 
al., 2009). As a result this method is able reduce bacterial population sizes, thus preventing them 











Other Applications of EPG 
 The use of EPGs on cooling tower sanitation is a novel method, but PEFs have been used 
in other areas to kill bacteria cells. Al-Sakere et al. (2007) used the PEF method as a minimally 
invasive way to treat tumors. In another study, PEFs were evaluated to sanitize hospital waste 
water to as a potential alternative to chlorination and prevent halogenation of organics within the 
waste water (Emmanuel et al., 2004). Finally, the most common use for PEFs is for 
electroporation to insert materials into the cell (Weaver and Chizmadzhev, 1996). 
Study Focus 
 This study used two EPG units developed by EET to sanitize cooling towers. We 
evaluated the STD EPG unit EET uses for all their installations and an EXP EPG unit that has 
been modified to be more effective than the STD EPG (Figure 3). These units both treat the 
water with an electrical pulse, but with different pulse signals. The STD EPG has an exponential 
decay function signal and the EXP EPG has a square wave signal, so the electrical pulse could 
penetrate deeper into the water. The STD EPG with its exponential decay function signal allows 
it to be used as a coil wrapped or skid-based system, while the EXP EPG can only be used as a 
skid-based system interfaced with a cooling tower. EET will use this evaluation to determine if 
the changes to the EXP EPG have improved the ability of EPGs to sanitize cooling towers. 
 
Figure 3: EPG installations STD EPG on left, EXP EPG on right. 





Goals, Objectives, and Hypotheses 
Goal: Prevent cooling towers from being a source of contamination and potential risk to public 
health. 
Objectives: 
1. Determine which device is more effective at removing bacteria by comparing the 
bacterial levels of the STD EPG to the EXP EPG.  
Hypothesis: If the EXP EPG is effective, it will have lower bacterial CFUs compared to the 
STD EPG. 
2. Determine if microbial populations remaining in the water systems are of similar 
diversity composition between the two treatments. 
Hypothesis: If the EXP EPG is effective, it will have lower microbial diversity. 
3. Determine abundance of antibiotic resistant bacteria in the water after treatment. 
Hypothesis: The EXP EPG will have a lower presence of antibiotic resistant bacteria. 
Chapter 2: Preliminary Methods and Results 
This research was based off of findings from preliminary research. The first preliminary 
methods were conducted from November 2018 to July 2019 on the Rochester campus of the 
Rochester Institute of Technology (RIT). This period sampled three cooling towers within 
building 2 (BLD 2) which was the Frank Ritter Ice Arena, building 14 (BLD 14) the Hugh L. 
Carey Hall and building 76 (BLD 76) the Chester F. Carlson Center for Imaging Science. BLD 
14 was treated with the EXP EPG, while BLD 2 and BLD 76 were treated with the STD EPG. 
This method tested for fungi using SAB plates, antibiotic resistance using the Kirby-Bauer disc 
diffusion method, and heterotrophic bacteria using Millipore HPC Red Test Samplers (HPC 
Samplers) and R2A plates (Figure 4). The results found no fungi present and no substantial 
difference between the EPG treatments. However, the heterotrophic bacteria below allowable 




resistant bacteria was present in both EPG treatments (Figure 6). The antibiotics used in the 
preliminary methods were the same antibiotics used in experimental methods. These findings 
sparked a deeper study into antibiotic resistance of the cooling tower bacterial population and a 
change in the EXP EPG pulse signal. Therefore in the 2020 sampling period the EXP EPG had 
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Figure 6: Antibiotic resistance levels of bacteria from BLD 14, BLD 76, and BLD 2. The 
bacteria were identified by their colony color. All cooling towers had antibiotic resistant 




The second preliminary method utilized the new EXP EPG and a split treatment system. 
This split system was equipped only on the cooling tower in BLD 14 because it was the only one 
running in the winter from December 2019 to February 2020, when this sampling occurred. The 
purpose of the split system was to test each EPG on the same cooling tower and remove 
variability possibly caused by unique environmental conditions of each particular tower. The 
split treatment system treated the water from the water basin in BLD 14 with both the STD and 
EXP EPG (Figure 7). Therefore, each EPG unit took a sample of the water, treated it, and 
returned it to bulk water in the tower. A sample was taken from each EPG unit immediately after 
treatment and tested for fungi, heterotrophic bacteria, and antibiotic resistance using the same 
methods as the first preliminary method. 
The results of this second preliminary method continued to show the EPG treatments had 
very similar bacterial CFUs/ml (Figure 8, 9). This was attributed to the fact that after treatment 
by each unit, the water was replaced into the same basin. Additionally, even though samples 
were taken immediately after the EPG treatment there was likely not enough reaction time to 
isolate each particular treatment to compare their efficiency. Consequently, the mixing of the two 
treatments in the bulk water caused the samples EPG treatments to appear very similar. The 
Millipore Yeast and Mold Yellow Test Samplers consistently had little to no growth, indicating 
no presence of fungi in these cooling towers. Antibiotic resistance was also reported in these 
samples (Figure 10). Therefore this second method proved the split system was inadequate to 








Figure 7: Split system treatment. Water in the collection basin is treated in one of the EPG units and 
returned to the collection basin (Edreher at English Wikipedia and Zerodamage, 2012). A modification 
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Figure 8: Split system 2019-2020 R2A Plates heterotrophic bacteria results for the STD and EXP 
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Figure 9: HPC Samplers results using the split system from 2019-2020. Graph represents the 
STD and EXP EPG CFUs at 24hr increments. *lack of bars indicates CFU/ml of bacteria that 
were too numerous to CFU/ml. 
Figure 10: Antibiotic resistance in the split system 2019-2020. Bacteria had 4%-75% antibiotic 





Chapter 3: Experimental Methods 
Sampling Sites 
Sampling sites were chosen from RIT’s Rochester campus due to their indoor and 
outdoor connecting cooling towers within a two mile square area to decrease variation in 
environmental conditions between cooling towers. BLD 2, the Frank Ritter Ice Arena was 
sampled from during the preliminary data collection period and was an indoor cooling tower 
equipped with the STD EPG. The cooling tower within BLD 14, Hugh L. Carey Hall, was 
selected because it was an indoor cooling tower thus only the cooling tower fills were exposed to 
the outside environment and this tower was functional all year round. BLD 14 was equipped with 
the EXP EPG since 2018, therefore was able to show how the EPG performs over a long period 
of time to reduce bacteria growth. From 2018-2019 the EXP EPG pulse signal was a square 
wave (step function) signal, preliminary data determined this signal did not improve the EXP 
EPG performance more than the STD EPG. As a result, the EXP EPG’s pulse width was 
increased and this adjusted EXP EPG was used for the 2020 sampling period starting in July. 
The cooling tower in BLD 76, the Chester F. Carlson Center for Imaging Science, had the STD 
EPG unit installed and was used as a control. BLD 76 was a seasonally functional cooling tower 
from late spring to late fall. It had an outdoor connection such that the cooling tower fills and 
water basin of the cooling tower were exposed to the outside environment. 
2020 Sample Collection 
In the summer and fall of 2020 (the 2020 sampling period) water samples were collected 
from BLD 14 and BLD 76. The STD EPG unit in BLD 76 was sampled the entire time it was 
functional. The EXP EPG unit in BLD 14 was sampled from July to September, then the EXP 
EPG was turned off and replaced by the STD EPG unit which was sampled from October to 
December. At each site three, 300 ml samples of water were collected immediately after 
treatment every two weeks. Then, the samples were placed on ice and refrigerated at 4℃ until 
analyzed (Figure 11). Samples were viable for 2 weeks, but analysis occurred as soon as 




   
  
 
Figure 11: Field sampling materials included water collection containers and a cooler filled with 





The microbial population of the water samples were tested for bacteria using nutrient 
agar and HPC Samplers. The HPC Samplers were used according to manufacturer's instructions. 
The indicated amount of sample water was poured into the container and the agar paddle was 
inserted into the water for 30 seconds. Then, the water was drained from the container and the 
HPC Samplers incubated for 3 days with bacteria counts taken every 24 hours (MilliporeSigma, 
2019) (Figure 14). If the number of colonies on the HPC Samplers were too numerous to count 
after 24 hours, the samples were tested again with a 10-1 dilution using distilled water. These 
HPC Samplers are what the industry uses to enumerate bacterial CFU/ml of cooling towers.  
The nutrient agar used for bacterial enumerations were R2A and PCA plates. R2A are the 
media recommended by the Center for Disease Control for water samples (Center for Disease 
Control, 2015). PCA plates are approved by the Public Health Association, Water Environmental 
Federation, and American Water Works Association for growing water sample bacteria (Baird et 
al., 2017). For this method, 0.1 ml of sample was serially diluted (10-2 to 10-4) with NaCl (Kim et 
al., 2004) (Figure 12). Then, 0.1 ml of the sample and the dilutions were spread on the nutrient 
agar plates and incubated at 30 ℃ (Figure 13). Bacterial counts were taken every 24 hours for 3 








Figure 12: Serial dilutions performed. Tubes contain 9 ml of 0.9% NaCl and 1 ml of sample 0.1 
ml of solution is plated on R2A plates (Leberechtc, 2010). 
















Figure 14: HPC Samplers (left) and nutrient agar plates (right) incubating at 30 ℃. 
 
Figure 13: Serial dilutions 10-1 to 10-4 results of STD (top row) and EXP EPGs (bottom row) after 





Identification of Isolates  
 Bacterial colonies were initially identified based on their macro physical characteristics 
such as colony color, colony morphology, and colony size (Ozdemir and Ceyhan, 2010). The 
bacteria identified were catalogued and given a letter designation. Then, the micro physical 
characteristics were used to further identify them based on their cell morphology and Gram-
staining reaction (Ozdemir and Ceyhan, 2010). After the bacteria were identified they were 
catalogued for which samples they were present in. The top 20 bacteria that were most frequently 
present in the samples were then consistently isolated so further testing could be performed on 
them and further identify attributes of the bacteria. 
Microbial Diversity 
The diversity of bacteria present in the cooling towers was evaluated by species richness. 
Species richness was the number of different bacteria present in a particular sampling population. 
The abundance of the species was determined by how frequently an identified bacteria was 
present in samples. This value was not the number of colonies of a bacteria present in a sample, 
but the number of times is appeared in sampling populations (ex. EPG treatment, season).  
Antibiotic Resistance 
The bacteria with the top 20 frequency presence were tested for antibiotic resistance 
using the Kirby Bauer disc diffusion method (Hudzicki, 2016). Colonies were grown in 10 ml of 
TSB broth for 48 to 72 hours at 30 ℃, shaking at 140 rpm. Aseptic technique with a sterile swab 
was used to streak the broth culture on a Muller-Hinton agar plate to form a bacterial lawn. The 
plate was allowed to dry for about 5 minutes then, antibiotics were dispensed on the agar. The 
following antibiotics were used: ceftriaxone, amikacin, levofloxacin, ampicillin, amoxicillin/ 
clavulanic acid, ticarcillin, doxycycline, sulfamethoxazole/ trimethoprim, ciprofloxacin, 
mezlocillin, cefixime, lomefloxacin, carbenicillin, tobramycin, imipenem, cephalothin, oxacillin, 
piperacillin, cefepime, sulfadiazine, minocycline, and meropenem. These antibiotics were chosen 
since they are currently in clinical use in hospitals (Whitburn, 2019). To ensure attachment of 
each antibiotic disc flame-sterilized forceps pressed each antibiotic disc to the agar. The plates 




each bacterium’s reaction to the antibiotic. A ruler recorded the diameter of the zones of 
inhibition in millimeters (Figure 15). Finally, the zones of inhibition were compared to published 
manufacture standards to determine the resistance to antibiotics of these bacteria (Hudzicki, 
2016; Becton Dickinson and Company, 2011). Antibiotic zones of inhibition which determined 
antimicrobial susceptibility can vary based on specific bacteria (Becton Dickinson and Company, 
2011). However, the bacteria identity was not determined prior to this test. Therefore, the 
reference zones of inhibition which determined antimicrobial susceptibility were based on the 
highest resistance zones of inhibition for each antibiotic, rather than specific bacteria. Antibiotic 









Figure 15: Kirby Bauer disc diffusion method. Bacteria was plated on Muller-Hinton plates with 
antibiotic discs. Bacterial resistance was measured by the diameter of the zone of inhibition 





Bacterial Identification of the 16S rRNA Gene 
 A subset of the bacteria found in the water samples were identified using their 16S rRNA 
gene. The subset of bacteria was decided because they had a high frequency presence in the 
water samples and were more than 60% resistant to the 24 antibiotics. The 16S rRNA gene was 
chosen since it was a sufficient sequence length to reflect important sequence changes that 
identify bacterial genera. To isolate the bacteria for gene sequencing, pure cultures of the 
bacteria were grown on PCA plates for 72 hours and stored at 4℃. Then Polymerase Chain 
Reaction (PCR) was performed on the bacteria such that the 16S rRNA gene 3 and 4 variable 
regions (V3/V4) were amplified using the primers 314f (5’-CCTACGGGNGGCWGCAG-3’) 
and 805r (5’-GACTACHVGGGTATCTAATCC-3’) (Klindworth et al., 2013; Parthasarathy et 
al., 2019). The PCR master mix solution used 10.5 µL H2O Rnase Free Sterile Water, 1 µL of 
the forward primer, 1 µL of the reverse primer, and 12.5 µL of the GoTaq™ Green (Promega) 
per each bacteria sample. Then a small amount of bacteria was added to the solution. Finally, the 
whole solution was placed in a thermocycler. The thermocycler PCR conditions were based on 
those used in Parthasarathy et al. (2019) edits to these methods were due to lab methods 
developed by Dr. Andre Hudson’s lab at RIT. The first cycle was for two minutes at 95 ℃, then 
30 cycles for 30 seconds at 95 ℃, 3 minutes at 72 ℃, five minutes at 72 ℃, and the temperature 
was held at 4 ℃. Next, gel electrophoresis and gel extraction was used to confirm the V3/V4 
amplifications using the QIAquick Gel Extraction Kit (Qiagen) and Sanger nucleotide 
sequencing of the 314f and 805r primers (Parthasarathy et al., 2019). The gel for the gel 
electrophoresis was made using 0.7 g of Agarose and 100 mL of 1 x TAE. Then, 5 µL of the 
DNA samples and the ladder were inserted into the wells and the gel was run for 45 minutes. 
Then the gel was placed in a UV light box and the presence of fluorescent bands indicated 
successful DNA extraction (Figure 16). Next, the samples were purified using the EZ-10 Spin 
Column PCR Products Purification Kit (Bio Basic Inc., 2015) (Figure 17). In an EZ-10 column 
20 µL of the PCR product, previously used for the gel electrophoresis, was combined with 150 
µL of binding buffer II and centrifuged at 10,000 rpm for 1 minute. Then, the flow through 
contents were discarded and 200 µL of wash solution was added to the column and centrifuged 
at 10,000 rpm for 2 minutes. The column was transferred into a 1.5 ml microfuge tube and the 




column. The column and microfuge tube were spun in a centrifuge together at 10,000 rpm for 1 
minute to elute the DNA. A NanoDrop fluorometer was used to find the DNA quantity of the 
PCR products. Preparation of the samples to send to Genewiz sequencing required to addition of 
1 µL of the forward primer, H2O RNASE free sterile water, and purified PCR product template 
DNA to a 1.5 ml microfuge tube. The equations 1 and 2 were used to determine the amount of 
purified PCR product template DNA and H2O RNASE free sterile water. Finally, the samples 
were sent to Genewiz for sequencing and the Basic Local Alignment Search Tool (BLAST) 
identified the bacteria genera based on the sequence (Parthasarathy et al., 2019). 
Equation 1: Purified PCR product template DNA 
Amount of template DNA =  20 ÷  Nucleic Acid (ng/µL) 
Equation 2: H2O RNASE free sterile water 












Figure 17: Electrophoresis gel results under UV light. The ladder was run on the farthest left well and 
the samples bands were run in the well to the right of it. 
Figure 16: Solutions used for DNA preparation to send to Genewiz from the EZ-10 Spin Column 






 A statistical analysis was performed using the statistical software R and Minitab. The 
cooling tower bacterial loads of CFUs/ml were evaluated statistically for sameness using one 
way blocked ANOVAs with incubation time as the blocking variable. The hypothesis for these 
tests were:  
1) The bacterial CFUs from each building would be the same throughout the sampling 
period with the same EPG.  
2) Seasonality would not affect bacterial CFUs therefore, CFUs/ml would be statistically 
the same throughout the fall and summer sampling periods in 2020. 
3) The bacterial CFUs would be statistically different from each EPG treatment. 
Tukey’s honesty significant difference test (Tukey’s HSD) followed these tests if there was a 
significant difference to determine which sample means were significantly different. 
The Gram stain results were statistically evaluated to determine which bacteria Gram 
stain identification was most present in the cooling towers. One proportion Z tests and goodness 
of fit tests were respectively used to determine Gram stain presence and distribution. Finally, the 
EPG comparisons and comparisons between buildings were evaluated using two-sample t-tests. 
Chapter 4: Bacteria Enumeration 
Results 
EPG Comparison of CFUs Results 
The results from the EXP and STD EPG from December 2018 to December 2020 showed 
the bacteria levels fluctuate throughout the year and did not appear to have a seasonality trend 
(Figure 18, 19). Overall the STD EPG was able to keep bacterial levels below 6.6 log CFU/ml 
(Figure 18). The bacteria enumerations from the EXP EPG were all below 6 log CFU/ml 
indicating the EXP EPG was able to have a lower maximum bacteria CFU threshold as 
compared to the STD EPG (Figure 19). The EXP EPG also had a negative linear trend, thus as 
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Statistical Analysis of Bacteria Enumeration 
The EPG devices were evaluated statistically using two sampling periods during 2020. 
The preliminary samplings before July of 2020 were excluded from this analysis because the 
EXP EPG had changes made to its PEF to improve its ability to lyse bacterial cells. The 
sampling period deemed summer sampled from July to September. During this period BLD 14 
was treated with the EXP EPG and BLD 76 was treated with the STD EPG. The sampling period 
deemed fall was from October to December where both BLD 14 and 76 were treated with the 
STD EPG. The 2020 sampling period allowed for a paired comparison of the EPGs and buildings 
at the same dates. 
Summer Sampling Period Statistical Results 
The microbial enumerations of BLD 14 and 76 samples grown on nutrient agar during the 
summer sampling period indicated a large amount of variation with a sum of squares of 288.3 
(Figure 20, Table 1). The samples taken within the same tower had a large variance. A one way 
blocked ANOVA that used incubation time as a blocking variable determined there were 
significant differences in the bacteria CFUs of each sample (Table 1). A Tukey’s HSD found that 
many of the samples were significantly different from each other and there was not a trend which 
indicated if sampling date or building was the cause of these differences (Table 2). Due to the 
high frequency of variation between all the samples each tower was evaluated independently to 
determine if the variance was due to the EPG treatment or another factor. The independent 
analysis of BLD 14 and 76 had a significant p-value indicating the bacteria levels within the 
same building’s cooling tower were different from each other (Table 1). Therefore, the bacterial 
CFUs throughout this sampling period were not uniform within each tower, which was 
unexpected. 
The HPC samplers results were also statistically analyzed using the same tests as those 
conducted on the nutrient agar counts. These revealed that some of the sampling dates and 
buildings tested with the different EPG units were significantly different (Table 1). A Tukey’s 
HSD showed the significantly different samples were samples from the same building and EPG 




significantly (Appendix C). A two-sample t-test also revealed the EPG treatments did not cause a 
significant difference in CFUs/ml of bacteria (Table 3). 
Fall Sampling Period Statistical Results 
During the fall sampling period both cooling towers were treated with the STD EPG. 
This was used to compare the bacterial levels within each building’s cooling tower to see if the 
conditions of each cooling tower would impact CFUs/ml. The results of one way blocked 
ANOVA of all the samples in the fall sampling period from the nutrient agar counts and HPC 
test samplers both concluded there were a significant differences in CFU/ml between each 
sample (Table 6; Figure 21). The Tukey’s HSD of the nutrient agar and HPC test sampler 
enumerations proved there was variance between the samples even though the EPG treatment 
was the same throughout the sampling period (Table 7, 9). The nutrient agar Tukey’s HSD 
indicated there were significant differences were between BLD 14 and BLD 76 samples, where 
five of the 12 comparisons of the buildings were significantly different (Table 7). In comparison, 
the HPC test sampler differences were due to variances between the buildings and between the 
sampling dates 10/12 and 10/26 (Table 9). A two-sample t-test was run on the HPC test sampler 
results to compare the building CFUs which found the CFU levels between the buildings were 
distinct, where BLD 76 had higher CFUs than BLD 14 (Table 4, 5). Therefore, the individual 
cooling towers had an affinity to have unique bacterial loads even when treated with the same 
EPG device. However, a further analysis was performed independently on each buildings to 
confirm this. 
A one way blocked ANOVA with a blocking variable of incubation time was run on the 
nutrient agar CFUs of BLD 76. This test was used to determine if there was a difference in the 
microbial CFUs between sampling dates. The tests results found there was not a difference 
between the samples, thus indicating the bacteria load within the BLD 76 using the STD EPG 
was uniform throughout the sampling period (Table 6). The same test was run on BLD 14, which 
resulted in a p-value that was less than the alpha indicating there was a significant difference in 
the samples (Table 6). Tukey’s HSD indicated the samples from 12/1 were significantly different 




homogenous bacterial load expect in 12/1. Therefore, conditions in each cooling tower were 
distinct from each other yet homogenous within each tower.  
Statistical Comparisons of EPGs Results 
In comparing all the samples CFUs in the 2020 sampling period using a two-sample t-test 
it was determined the bacterial CFU levels did not differ by their EPG treatment (Table 10). In 
addition, a two-sample t-test was performed on the summer period and all the BLD 14 samples. 
The summer period was used to compare the different EPGs bacterial growth during the same 
time periods. The BLD 14 was used to compare the different EPGs bacterial growth within the 
same cooling tower to hold the building variable constant since each buildings environmental 
conditions are unique and may be influencing bacterial levels. In evaluating the CFUs from all 
the sampling in BLD 14 it was determined that EPGs had an equal effect on the cooling tower 
CFUs (Table 10). The same was found for the summer sampling period results which compared 
the EXP and STD EPGs (Table 3). Therefore, these devices were unable to show that one EPG 
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Table 1: One way blocked ANOVA with incubation time was used as the blocking variable for 
samples in the summer sampling period (p ≤0.05). 
One Way ANOVA Test Samples Df Sum Sq Mean Sq F value P-value 
All Samples Nutrient Agar CFUs 11 288.3 26.21 13.72 <2e-16 *** 
Bld 14 Samples Nutrient Agar CFUs 5 157.4 31.482 15.22 2.08e-12 *** 
Bld 76 Samples Nutrient Agar CFUs 5 129.53 25.905 14.846 4.2e-12 *** 






Table 2: Tukey’s HSD in the summer sampling period for all samples of the nutrient agar CFUs. 
This table only represents the compared samples that were significantly different from each 
other.  
Comparison of Samples P-value 
7/6/20 Bld 14-7/21/20 Bld 14 0 
7/6/20 Bld 76-7/21/20 Bld 14 0 
8/3/20 Bld 14-7/21/20 Bld 14 0 
8/3/20 Bld 76-7/21/20 Bld 14 0 
7/6/20 Bld 14-7/21/20 Bld 76 0 
7/6/20 Bld 76-7/21/20 Bld 76 0 
8/3/20 Bld 14-7/21/20 Bld 76 0 
8/3/20 Bld 76-7/21/20 Bld 76 0 
8/25/20 Bld 14-7/6/20 Bld 14 0 
8/25/20 Bld 76-7/6/20 Bld 14 0 
9/22/20 Bld 14-7/6/20 Bld 14 0 
9/22/20 Bld 76-7/6/20 Bld 14 0 
9/8/20 Bld 14-7/6/20 Bld 14 0 
9/8/20 Bld 76-7/6/20 Bld 14 0 
8/25/20 Bld 14-7/6/20 Bld 76 0 
8/25/20 Bld 76-7/6/20 Bld 76 0 
9/22/20 Bld 14-7/6/20 Bld 76 0 
9/22/20 Bld 76-7/6/20 Bld 76 0 
9/8/20 Bld 14-7/6/20 Bld 76 0 
8/3/20 Bld 14-8/25/20 Bld 14 0 
8/3/20 Bld 76-8/25/20 Bld 14 0 
8/3/20 Bld 14-8/25/20 Bld 76 0 
8/3/20 Bld 76-8/25/20 Bld 76 0 
9/22/20 Bld 14-8/3/20 Bld 14 0 





Table 2 Continued 
Comparison of Samples P-value 
9/22/20 Bld 14-8/3/20 Bld 76 0 









Table 3: Two-sample t-test on the HPC Samplers comparing CFU/ml from each EPG treatment 
during the summer sampling period (p ≤ 0.05). 
Two-sample t-test Results Df T- value P-value 
All Summer Samples HPC Samplers 105 0.09 0.930 
 
Table 4: Two-sample t-test on the HPC Samplers comparing CFU/ml from each building in the 
fall sampling period (p ≤ 0.05). 
Two-sample t-test Results Df T- value P-value 
All Fall Samples HPC Samplers Compared by BLD 60 -3.93 0.00 
 
Table 5: Descriptive statistics of two-sample t-test on the HPC Samplers comparing CFU/ml 
from each building in the fall sampling period (p ≤ 0.05). 
Building N Mean StDev SE Mean 
Bld 14 36 475 786 131 
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Table 6: One way blocked ANOVA on nutrient agar CFUs in the fall sampling period with 
incubation time as blocking variable. 
Sample Populations Df Sum Sq Mean Sq F value P-value 
All Fall Sampling Period Nutrient 
Agar CFUs 6 86.9 14.49 7.25 3.9e-07 *** 
All Fall Sampling Period HPC 
Samplers CFUs 6 29.140 4.8566 8.51 0.000*** 
Fall BLD 76 Nutrient Agar CFUs 2 9.08 4.538 1.682 0.191 






Table 7: Tukey’s HSD of all the fall 2020 samples of the nutrient agar CFUs. *bold values 
indicate a significant difference between samples 
Comparison of Samples P-value 
10/12/20 Bld 76-10/12/20 Bld 14 0.8915605 
10/26/20 Bld 14-10/12/20 Bld 14 0.9820173 
10/26/20 Bld 76-10/12/20 Bld 14 0.116753 
11/9/20 Bld 14-10/12/20 Bld 14 0.7582261 
11/9/20 Bld 76-10/12/20 Bld 14 0.0197647 
12/1/20 Bld 14-10/12/20 Bld 14 0.0729359 
10/26/20 Bld 14-10/12/20 Bld 76 0.3972033 
10/26/20 Bld 76-10/12/20 Bld 76 0.7786506 
11/9/20 Bld 14-10/12/20 Bld 76 0.1071202 
11/9/20 Bld 76-10/12/20 Bld 76 0.3678941 
12/1/20 Bld 14-10/12/20 Bld 76 0.664001 
10/26/20 Bld 76-10/26/20 Bld 14 0.0107404 
11/9/20 Bld 14-10/26/20 Bld 14 0.9949631 
11/9/20 Bld 76-10/26/20 Bld 14 0.0010432 
12/1/20 Bld 14-10/26/20 Bld 14 0.0056496 
11/9/20 Bld 14-10/26/20 Bld 76 0.0009948 
11/9/20 Bld 76-10/26/20 Bld 76 0.995452 
12/1/20 Bld 14-10/26/20 Bld 76 0.9999963 
11/9/20 Bld 76-11/9/20 Bld 14 0.0000669 
12/1/20 Bld 14-11/9/20 Bld 14 0.0004673 






Table 8: Tukey’s HSD of the BLD 14 fall sampling period nutrient agar CFUs. *bold values 
indicate a significant difference between samples. 
Comparison of Samples P-value 
10/26/20 Bld 14-10/12/20 Bld 14 0.7730186 
11/9/20 Bld 14-10/12/20 Bld 14 0.32072 
12/1/20 Bld 14-10/12/20 Bld 14 0.0069521 
11/9/20 Bld 14-10/26/20 Bld 14 0.8745764 
12/1/20 Bld 14-10/26/20 Bld 14 0.0002306 






Table 9: HPC test samplers fall sampling period Tukey’s HSD. *bold values indicate a 
significant difference between samples 
Difference of Sample Levels P-Value 
10/12/2020 Bld 76 - 10/12/2020 Bld 14 0.582 
10/26/2020 Bld 14 - 10/12/2020 Bld 14 0.012 
10/26/2020 Bld 76 - 10/12/2020 Bld 14 0.627 
11/9/2020 Bld 14 - 10/12/2020 Bld 14 0.996 
11/9/2020 Bld 76 - 10/12/2020 Bld 14 0.146 
12/1/2020 Bld 14 - 10/12/2020 Bld 14 1.000 
10/26/2020 Bld 14 - 10/12/2020 Bld 76 0.000 
10/26/2020 Bld 76 - 10/12/2020 Bld 76 1.000 
11/9/2020 Bld 14 - 10/12/2020 Bld 76 0.226 
11/9/2020 Bld 76 - 10/12/2020 Bld 76 0.979 
12/1/2020 Bld 14 - 10/12/2020 Bld 76 0.690 
10/26/2020 Bld 76 - 10/26/2020 Bld 14 0.000 
11/9/2020 Bld 14 - 10/26/2020 Bld 14 0.062 
11/9/2020 Bld 76 - 10/26/2020 Bld 14 0.000 
12/1/2020 Bld 14 - 10/26/2020 Bld 14 0.007 
11/9/2020 Bld 14 - 10/26/2020 Bld 76 0.257 
11/9/2020 Bld 76 - 10/26/2020 Bld 76 0.969 
12/1/2020 Bld 14 - 10/26/2020 Bld 76 0.732 
11/9/2020 Bld 76 - 11/9/2020 Bld 14 0.033 
12/1/2020 Bld 14 - 11/9/2020 Bld 14 0.985 







Table 10: Two-sample t-test of building comparisons from the all samples in the 2020 sampling 
period. 
Comparison of EPGs T-Value DF P-value 
Nutrient Agar CFUs at 24 hr -0.67 40 0.507 
Nutrient Agar CFUs at 48 hr 0.41 30 0.686 
Nutrient Agar CFUs at 72 hr 0.54 27 0.592 
All 2020 Nutrient Agar CFUs 
Samples from BLD 14 at 48 hr 0.49 5 0.643 
HPC Samplers CFUs at 48 hr 0.09 30 0.930 
Discussion 
EPG Comparison  
The acceptable levels for heterotrophic bacteria in cooling towers are 5 log CFUs 
(Monash University, 2017). The EXP and STD EPGs both surpassed this level at one point or 
another but it was relatively infrequent and the bacteria load was quickly reduced below this 
level (Figure 18, 19). About 20% of the samples from the EXP EPG were above 5 log CFUs. 
However, the sampling period following the high bacterial load usually had CFUs that were 
reduced below this limit (Figure 19). In contrast the STD EPG had a higher CFU limit, 6.6 log 
CFUs but, this only occurred twice in the 30 STD EPG samples. This occurrence was during the 
preliminary data collection in BLD 2 where sampling was later discontinued due to the loss of 
sanitation contract. Excluding the two abnormally high CFUs in BLD 2, the STD EPG maximum 
CFUs was 4.7 log, therefore all of the STD EPG CFUs were below the allowable limit.  
The cause of the excessive bacterial growth in either EPG was unclear, though it did not 
appear to be associated with seasonality. There were not trends that suggested seasonality 
affected bacterial CFUs because the same month could have very different CFUs (Figure 18, 19). 
Additionally, the same sampling date could have profoundly different CFUs in different cooling 
towers. The relative abundance of bacteria changed over time, however each cooling tower did 




responsible for these changes (Tsao et al., 2019). Therefore in comparison, the STD EPG was 
able to reduce the bacterial load below the allowable levels more frequently than the EXP. 
Statistical Analysis of Microbial Enumeration  
The bacterial community in the summer sampling period determined there was a 
difference in means among the different samples tested by the EXP EPG in BLD 14 and the STD 
EPG in BLD 76. However, this did not prove the CFUs difference was due to the EPG device. 
Tukey’s HSD revealed a majority of the variation in this comparison was due to CFU variation 
within the same building. This indicated there was not uniformity within each building’s cooling 
tower, thus a factor other than the EPGs was influencing bacterial growth. Factors such as wind, 
weather, and seasonal climates may be affecting the bacterial community in the cooling towers 
causing the CFUs to be higher or lower at the time of sampling (Tsao et al., 2019). Additionally, 
these towers were monitored by RIT facilities, if bacterial levels got too high the EPGs may be 
overridden by a chlorine treatment to kill the excess of bacteria. This may have occurred on 
7/6/20 when bacteria CFUs were at 0. In conclusion, the statistical results were inconclusive as 
to why the summer period had so much variation, especially within their own towers. 
The fall sampling period followed the same trend of variance as the summer sampling 
period. Even though all samples were treated by the STD EPG device during this period the 
bacterial loads were not statistically the same. This further confirmed that each cooling tower has 
a unique environment (Tsao et al., 2019). BLD 76 being an outdoor tower had different 
environmental conditions that may have influenced the bacterial community differently than 
BLD 14 which was an indoor cooling tower. When each building was evaluated independently, 
the samples within BLD 76 had similar bacterial loads, this differed from the summer sampling 
period. BLD 14 during the fall sampling period also had homogeneous CFUs except for its 12/1 
sample, however this variance could have been caused by start of winter. This suggested the 
summer months caused bacteria loads to vary more significantly than fall months. Therefore, 
there may have been a seasonal effect where warmer months cause more variation in CFUs, than 
cooler months.  
Overall the STD EPG and the EXP EPG showed they controlled bacterial growth the 




However, the enumerations alone showed that the STD EPG was able to more frequently keep 
bacterial CFUs below allowable levels. Therefore, the STD EPG may be able to reduce CFUs 
better than the EXP EPG, however this was not proved statistically. 
Chapter 5: Bacterial Community  
Results 
Species Presence Results 
The bacteria that appeared in the cooling tower samples varied vastly. Species presence 
was determined by counting the number of times a bacteria, as identified by Appendix D, 
appeared in a sample. The frequency presence within the bacteria community of all the samples 
determined that only 18 of the 77 bacteria appeared in a sample more than 5 times (Figure 22). 
The top five bacteria that appeared most frequently in all the samples were present in all seasons, 
EPG treatments, and cooling tower buildings. In comparison of the EPG treatments 34 of the 
same bacteria was present in both the STD EPG (54% of the population) and EXP EPG 
treatments (71% of the population) (Figure 23, 24). Only 24 bacteria were present throughout 
both the summer and fall sampling seasons. The summer sampling period had 60% unique 
bacteria in their population, while the fall sampling period had 41% unique bacteria in their 
population (Figure 25, 26). Consequently, the STD EPG and summer sampling period had a 








Figure 22: Frequency bacteria appeared in all samples. This graph only represents the bacteria 




Figure 23: The common bacteria between the EPG treatments as a percent of the EXP EPG 


























Figure 24: The common bacteria between the EPG treatments as a percent of the STD EPG 



















Figure 26: The common bacteria between seasons as a percent of the fall sampling period 
bacterial population. 
Species Richness Results 
The bacterial species richness of the samples was collected to determine the diversity of 
the bacterial communities within the cooling towers. The species richness was a count of the 
different bacteria that appeared in the samples. The overall richness of all the samples was 77 
species. In comparison of the EPGs the STD EPG had a higher species richness than the EXP 
EPG (Table 11). The summer sampling period which compared the EPG devices on the same 
dates found the EXP EPG had a species richness of 48, while the STD EPG had a species 
richness of 42 in the summer sampling period. Therefore, the samples taken at the same time 
from the different EPGs showed a similar diversity. However in observing all the 2020 samples, 
the EXP EPG had a lower species richness (Table 11). This could be due to the fact that there 
was more data on the STD EPG inflating its diversity. The STD EPG overall in the fall sampling 
period had lower diversity than the summer. Therefore, the comparison in the summer period 
was more accurate to compare the EPG treatments.  
In observing each building individually, BLD 76, which was only treated by the STD 
EPG, had a species richness of 55, while BLD 14 which was treated by both the EXP and STD 
EPG had a species richness of 59 (Table 11). Therefore, the bacteria diversity between these 








significantly in the fall sampling period. The diversity in BLD 14 in the summer sampling period 
had a species richness was 48, however the fall sampling period showed a drop in diversity to 28. 
BLD 76 had a decline in species richness from 42 to 9 from the summer to fall sampling period. 
Seasonality proved the summer sampling period had a higher species diversity than the fall 
(Table 11). 
 
Table 11: Bacterial species richness present in different sampling populations. 
Sample Population Species Richness 
Bacteria Presence of All Samples (all BLDs, EXP & STD EPG) 77 
STD EPG Richness 63 
EXP EPG Richness 48 
Summer Sampling Species Richness (Both EXP & STD EPG) 60 
Fall Sampling Species Richness (STD EPG) 41 
BLD 76 Richness All Samples (STD EPG) 55 
Summer Sampling Richness of the STD EPG in BLD 76  42 
Fall Sampling Richness of the STD EPG in BLD 76  9 
BLD 14 Richness All Sampling (Both EXP & STD EPG) 59 
Summer Sampling Richness of the EXP EPG in BLD 14 48 
Fall Sampling Richness of the STD EPG in BLD 14 28 
Gram Stain Results 
From the cooling tower water samples, 77 distinct bacteria were identified. Of those 77 
identified 72 were able to be successfully Gram stained, the inability to Gram stain was due to 
issues isolating particular bacteria. All Gram stains are described in Appendix E. The Gram 
stained bacteria had was a higher frequency (55%) of Gram negative bacteria (43), than Gram 
positive bacteria (29) (Table 12), although this was not a statistically significant majority (Table 
13). Of the different treatments Gram negative bacteria held the statistical majority in the STD 
EPG treatment samples, while there was an even distribution of Gram negative and positive 
bacteria in the EXP EPG treatment samples (Table 13). Those that were Gram negative were 




of bacillus (15) and coccus (14) (Table 12). A goodness of fit test was run on the Gram stain and 
shape results to determine which Gram stain result was most present in the samples. This proved 
the distribution of the Gram stain results was not equal (p-value 0.013). The Gram negative 
bacilli had the highest presence and the most influence in disrupting the equal distribution of the 
bacteria Gram stain results since the observed frequency was much higher than the expected 
frequency of Gram negative bacilli (Table 14). These results showed that Gram negative bacilli 
were the dominant bacteria present in cooling towers and the EXP EPG was able to reduce Gram 
negative populations more effectively than the STD EPG. 
 
Table 12: Summary of Gram stain results. 
Gram Stain Results Frequency 
Gram Negative 43 
Bacillus 30 
Coccus 13 
 Gram Positive 29 
Bacillus 15 
Coccus 14 
unable to isolate for gram stain 5 
 
Table 13: 1 Proportion Z test on the Gram stains from the bacteria documented in the samples. 
These tests were performed such that Gram negative was ≠ 0.5 to determine if Gram negative 
bacteria were the majority of the bacteria in the tower. 
 Samples N Event 95% Confidence Interval  Z-Value P-Value 
All Bacteria Gram Stains 72 43 0.4818067, 0.7027889 1.65 0.09896 
STD EPG Bacteria Gram Stains 61 38 0.517716, 1.000000 3.6885 0.02739 






Table 14: Chi square goodness of fit Gram stain result contributions. 
Category Observed Test Proportion Expected Contribution to Chi Square 
negative bacillus 30 0.25 18 8.00000 
negative coccus 13 0.25 18 1.38889 
positive bacillus 15 0.25 18 0.50000 
positive coccus 14 0.25 18 0.88889 
Antibiotic Resistance Results  
A subset of the bacteria that were frequently present in the cooling towers was tested for 
antibiotic resistance. These bacteria had the top 20 highest presence in the towers, meaning they 
appeared in the cooling tower samples more than four times with one appearing only three times. 
Half of the tested samples were resistant to 50% or more of the 24 antibiotics tested (Figure 27). 
Of the bacteria present in each EPG treatment which were tested for antibiotic resistance, 60% of 
the bacteria in the EXP EPG treatment and 50% of the bacteria in the STD EPG treatment were 
resistant to at least half of the antibiotics (Table 15, 16). The STD EPG contained more bacteria 
that were antibiotic resistant than the EXP EPG. Of the antibiotics tested, ampicillin and 
oxacillin were obsolete, all of the bacteria tested were 100% resistant to them. Imipenem, 
doxycycline, minocycline, and levofloxacin were most effective (85-95%) against the cooling 
tower bacteria, with 15% or less of resistance to these antibiotics (Figure 28). 
The bacteria present in the cooling towers did not always have a uniform bacterial 
population. In some cases the bacterial community contained multiple populations that had 
different antibiotic sensitivities even though they were grown as a pure culture. Of the bacteria 
tested, 62% of them contained multiple populations that were resistant and sensitive to one or 
more antibiotic (Figure 29). In these cases the bacteria zones of inhibition were based on their 







Figure 27: Cooling tower bacteria antibiotic resistance. 
 
 























































Table 15: EXP EPG antibiotic resistance and bacteria frequency. 
Bacteria Designation Frequency in samples % Antibiotic Resistance 
RY 6 88% 
YL 5 85% 
DY 4 79% 
BBW 4 77% 
CW 6 77% 
BY 10 69% 
F 2 60% 
UK 3 60% 
FY 5 58% 
T 10 54% 
BC 4 50% 
UY 3 50% 
BW 7 46% 
DLY 2 40% 
RW 8 40% 
WC 7 29% 
B 3 27% 
O 3 25% 
PY 3 19% 






Table 16: STD EPG antibiotic resistance and bacteria frequency. 
Bacteria Designation Frequency in samples % Antibiotic Resistance 
RY 1 88% 
BBW 1 77% 
CW 3 77% 
BY 3 69% 
F 2 60% 
UK 1 60% 
T 5 54% 
UY 2 50% 
BW 3 46% 
DLY 1 40% 
RW 2 40% 
WC 1 29% 
B 3 27% 
O 1 25% 
PY 1 19% 







Figure 29: Image of antibiotic sensitivity test on BC bacteria showing multiple populations with 
different antibiotic sensitivities. The antibiotic under the BC label and going clockwise the 4 th 




16S rRNA Gene Bacterial Identification 
The results of the 16S rRNA sequencing from Genewiz found the genera of each bacteria and 
in most cases the species or likely species. Therefore the species that were present in the cooling 
towers were Morganella morganii, Chryseobacterium ureilyticum, Phenylobacterium sp., 
Chryseobacterium cucumeris, Stenotrophomonas maltophilia, Bacillus licheniformis, and 
Bacillus cereus (Table 17). The Gram stains and images of these bacterial colonies are presented 
in Appendix F. The bacteria identified through the 16S rRNA gene had some discrepancies on 
the Gram stain results as compared to the reported Gram stain for the identified bacteria (Table 
17). These bacteria were the most common bacteria and all were resistant to more than 46% of 
antibiotics tested on them (Table 17, 18). 
 
Table 17: Bacteria that was identified by the 16S rRNA gene attributes. 
Bacteria 





BW Morganella morganii positive coccus negative bacillus 46% 
BY 
Chryseobacterium 
ureilyticum negative bacillus negative bacillus 69% 
CW Phenylobacterium sp. positive coccus negative bacillus 77% 
DY 
Chryseobacterium 
cucumeris negative bacillus negative bacillus 79% 
RY 
Stenotrophomonas 
maltophilia  negative bacillus negative bacillus 88% 
T Bacillus licheniformis negative bacillus positive bacillus 54% 






Table 18: Antibiotic resistance of the bacteria that had their 16S rRNA gene sequenced. R 
indicates resistant, S susceptible, and I intermediate antibiotic sensitivity. 
 
Bacteria Designation 
Antibiotic BW BY CW DY RY T UK 
Ampicillin R R R R R R R 
Amikacin S R S R R S S 
Amoxicillin/ 
Clavulanic acid 
R R R R R R R 
Carbenicillin S R R R R R R 
Cefazolin R R R R R I R 
Cefepime S S R R R R R 
Cefixime S R R R R R R 
Cefoxitin R R R R R S R 
Ceftriaxone S R R R R R R 
Cephalothin R R R R R R R 
Ciprofloxacin I I R R R I I 
Doxycycline R S S S S S S 
Imipenem S S R S R S S 
Levofloxacin S S R S S S S 
Lomefloxacin R I I R R R I 
Meropenem S R R R R S S 
Mezlocillin I R R R R R I 
Minocycline S S S S S S S 
Oxacillin R R R R R R R 
Piperacillin R R R R R R R 
Sulfadiazine R I S R R S S 
Sulfamethoxazole/ 
Trimethoprim 
S S S S R S R 
Ticracillin S R R R R R R 






In comparing all the samples taken in the 2020 sampling period the STD EPG had a 
higher species richness than the EXP EPG (Table 1). This could indicate the EXP EPG was able 
to reduce bacteria diversity more effectively than the STD EPG. However, there were more 
samples treated with the STD EPG than the EXP EPG which may have skewed the data. 
Therefore, the population of the summer sampling period was examined to compare diversity of 
each EPG treatment on the same sampling dates. This revealed that the EXP and STD EPG had 
very similar species richness. The increase of data for the STD EPG and the significant decline 
in diversity in the fall sampling period was likely why the comparison of all samples made the 
EXP EPG appear as though it reduced bacterial diversity more effectively than the STD EPG. 
The summer sampling period was a more robust analysis of diversity when comparing the EPGs, 
thus the EPGs have very little difference in their ability to reduce bacterial diversity and 
CFUs/ml.  
Species Presence and Richness 
Microbial diversity within cooling towers has been a neglected area of study. Few studies 
have evaluated bacteria within cooling towers beyond those in association with L. pneumophila 
presence (Tsao et al., 2019). This evaluation of diversity determined the species richness and 
frequency presence of bacteria within cooling towers in order to evaluate the EPG devices ability 
to reduce species diversity. Of the 77 species that were present in all the cooling towers only 
23% of them appeared in the samples more than 5 times, thus species presence was variable. 
However, the top five bacteria that had the highest frequency presence were not affected by 
seasons, specific cooling tower building conditions, or the EPG treatment. Therefore, there were 
some bacteria that were constant no matter the conditions. 
The majority of bacteria were consistent between the EPG treatments. The between the 
EXP and STD EPG there were 34 bacteria that appeared in both of the treatments. Based on the 
species richness of the EXP EPG, these 34 bacteria accounted for 71% of the population, while 




STD EPG fostered a more diverse bacterial community, while the EXP EPG had a simpler 
community. This was in agreement with the species richness results where the STD EPG had a 
higher species richness than the EXP EPG.  
The reduction in diversity could be the result of seasonality. Twenty-four bacteria were 
present throughout both the summer and fall sampling seasons. Those 24 consistent bacteria 
accounted for 40% of the population in the summer sampling period, while in the fall sampling 
period it accounted for 59% of the bacterial population (Figure 25, 26). Therefore, there were 
more unique species in the summer than the fall, suggesting there was a trend in seasonality 
since there was more diversity in the summer than the fall. 
Species richness also showed this seasonality trend. Species richness significantly 
decreased from the summer to fall sampling periods. The species richness in BLD 76 declined 
from 42 to 9 species, whereas the species richness in BLD 14 decreased from 48 to 28 species. In 
BLD 14 the EPG treatment also changed between the summer and fall sampling periods, yet this 
diversity decline was more likely from seasonality than EPG treatment since the same diversity 
decrease also occurred in BLD 76 where the EPG device was the same throughout the 2020 
sampling period. Additionally, the EPG comparison in the summer sampling period found the 
EPG treatments resulted in similar diversities, thus the reduced diversity could not be due to EPG 
treatment but rather seasonality. The decrease in diversity could be due to the cooler weather 
conditions providing injurious conditions for some species (Tsao et al., 2019). The steeper 
decrease in the diversity in BLD 76 could be caused by its outdoor connection causing colder 
temperatures than within BLD 14 which is an indoor cooling tower. Therefore, seasonality had 
an effect on diversity. However, seasonality did not affect CFUs indicating that when some 
species were removed other species were able to thrive and grow to similar levels in their place. 
Lower diversities may be beneficial for sanitation since it results in fewer bacteria to be 
concerned about, yet they are in higher concentrations thus have a higher contamination potential 
if pathogenic. 
Gram stain  
Gram negative bacteria dominate cooling tower bacterial communities (Türetgen, 2004). 




opportunistic pathogens to immunocompromised humans (Center for Disease Control, 2015). 
The high frequency of Gram negative bacilli was concerning since cooling towers can 
contaminate large areas both indoors and outdoors and cause infections (Sala Ferré et al., 2009). 
The reduction of Gram negative bacteria in the EXP EPG as compared to the STD EPG indicated 
the EXP EPG can reduce the number of potentially pathogenic bacteria more effectively than the 
STD EPG. However, the bacteria tested in this study for antibiotic resistance had a relatively 
equal distribution of Gram negative and positive bacteria, which were both particularly resistant 
to the antibiotics tested (>60%) (Figure 15). As a result, although Gram negative bacteria is 
known to likely be pathogenic, in this study it did not indicate a higher affinity to antibiotic 
resistance. 
Antibiotic Resistance 
Although it is known that cooling towers are hotspots for biofilms where genetic 
exchange can occur, there are few studies that evaluate the antibiotic resistance within cooling 
towers (Fux et al., 2005; Hausner and Wuertz, 1999; Li et al., 2002; Molin and Tolker-Nielsen, 
2003; Ozdemir and Ceyhan, 2010). This study found that cooling towers had a high presence of 
antibiotic resistant bacteria. The antibiotics recommended for cooling tower usage are imipenem, 
doxycycline, minocycline, and levofloxacin since they had the highest efficiency (85-95%) 
against the cooling tower bacteria (Figure 16). Comparatively, it is not recommended to use 
ampicillin or oxacillin since cooling tower bacteria are likely to be resistant to them. These 
results were of concern because these antibiotics are widely used in clinical settings (Whitburn, 
2019). 
The presence of multiple populations of the same bacteria with different susceptibilities 
to antibiotics suggests bacteria are actively gaining antibiotic resistance. Sixty-two percent of the 
bacteria tested had multiple populations that were resistant and sensitive to one or more 
antibiotic, thus there is a significant amount of genetic exchange occurring in cooling towers 
(Figure 17). Genetic exchange in cooling towers would result in even fewer antibiotics able to 
suppress bacteria. Outbreaks from cooling towers frequently occur in hospitals, thus these 




able to use to treat bacterial infections resulting from cooling tower contamination (Dondero et 
al., 1980; Engelhart et al., 2008; García-fulgueiras et al., 2003). 
The presence of antibiotic resistant bacteria did not suggest that one of the EPG 
treatments was more effective to remove antibiotic resistant bacteria. However, the frequency 
antibiotic resistant bacteria appeared in samples was lower in the STD EPG than the EXP EPG 
(Table 15, 16). Therefore, although the STD EPG may allow the presence of antibiotic resistant 
bacteria their abundance will be lower. 
16S rRNA 
Bacteria that had a high frequency presence in the cooling towers had their 16S rRNA 
gene sequenced to identify the bacteria and determine what implications it could have on the 
environment if released from the tower. There were discrepancies in the Gram stain results of the 
bacteria isolated from the cooling towers as compared to the reported Gram stains from the 16S 
rRNA identified bacteria (Table 17). The experimental Gram stains could have been erroneous 
due to over or under use of decolorizer resulting in a false Gram stain. In addition the variance in 
bacteria shape could simply have been a misidentification.  
The species that were present in the cooling towers were Morganella morganii, 
Chryseobacterium ureilyticum, Phenylobacterium sp., Chryseobacterium cucumeris, 
Stenotrophomonas maltophilia, Bacillus licheniformis, and Bacillus cereus (Table 17). BW was 
determined to be M. morganii, however there was a discrepancy between the experimental Gram 
stain as Gram positive coccus, while the documented Gram stain is a Gram negative bacilli 
(Falagas et al., 2006). This error could be an excess of crystal violet or not enough decolorizer. 






Table 19: Summary of the contamination potential of the identified bacteria. 
Bacteria Contamination Potential 
Morganella morganii  Opportunistic pathogen 
 Broad resistance to antibiotics 
 Can easily transfer genetic material 
between bacteria. The isolate from this 
sample has additional antibiotic 
resistance than literature reports. 
 Not likely to cause infection through 
aerosol 
Chryseobacterium ureilyticum  Resistant to beta-lactams and 
carbapenems  
 Opportunistic pathogens 
Chryseobacterium cucumeris  Resistant to beta-lactams and 
carbapenems  
 Opportunistic pathogens 
Phenylobacterium sp.  Antibiotic resistance to ampicillin and 
carbenicillin 
 No known pathogenic properties 
Stenotrophomonas maltophilia  Resistant to a broad spectrum of 
antibiotics  
 This isolate had 88% antibiotic 
resistance 
 Can cause respiratory issues 






Table 19 Continued 
Bacteria Contamination Potential 
Bacillus licheniformis  Isolate with the highest frequency 
presence 
 Non-pathogenic 
 Forms spores  
 This isolate was sensitive to 
antibiotics it had known resistance to  
 Unlikely to transfer genes horizontally  
Bacillus cereus  Spore forming  
 Associated with food poisoning, 
respiratory tract infections, and 
nosocomial infections  
 Produce β-lactamases and 
carbapenemsases 
 NCCLS recommended the avoidance 
of cephalosporin for B. cereus 
treatment 
 Collected bacteria was susceptible to 
carbapenems  
 
M. morganii is considered an opportunistic species that persists in the intestines of 
animals (Mbelle et al., 2020). It is known to cause urinary tract infections (UTI), meningitis, and 
septic arthritis (Falagas et al., 2006; Katz et al., 1987; Mbelle et al., 2020; Samonis et al., 2001). 
It also has resistance to a variety of antibiotics and multiple drug resistance (Rojas et al., 2006). 
In addition, M. morganii has the ability to easily transfer gene resistance between bacteria of the 
same or different species (Hsieh et al., 2015; Liu et al., 2016; Mbelle et al., 2020; Rojas et al., 
2006). Literature has reported M. morganii to be resistant to oxacillin, ampicillin, amoxicillin, 
first and second cephalosporins, macrolides, lincosamides, glycopeptides, fosfomycin, fusidic 




This study agrees with these reports as M. morganii was resistant to ampicillin, 
amoxicillin/ clavulanic acid, and oxacillin, and cephalosporins: cephalothin, cefazolin, cefoxitin. 
In addition, M. morganii was resistant to doxycycline, piperacillin, lomefloxacin, and 
sulfadiazine (Table 18). Stock and Wiedemann (1998) also found M. morganii was susceptible to 
aztreonam, aminoglycosides, antipseudomonal penicillins, third-and fourth-generation 
cephalosporins, carbapenems, quinolones, trimethoprim/ sulfamethoxazole, and 
chloramphenicol. The results from this study are in line with these findings except this M. 
morganii was resistant to piperacillin and antipseudomonal penicillins, suggesting that while in 
the cooling tower M. morganii received genetic resistance genes.  
The antibiotic resistance, susceptibility to obtain new antibiotic resistance genes, and 
high abundance of M. morganii raised concerns for M. morganii’s presence in cooling towers. M. 
morganii is commonly known to cause UTIs in humans which is not communicated through 
breathing in an aerosol, however it has a high pathogenic potential in immunocompromised hosts 
(Samonis et al., 2001). Therefore, M. morganii in cooling towers are unlikely to pose a risk to 
human health directly, however their potential to gain and transfer antibiotic resistance to other 
pathogens raises a public health concern. 
The bacteria designated BY and DY were identified as Chryseobacterium ureilyticum 
and Chryseobacterium cucumeris. Chryseobacterium is a quickly growing genera that is 
characterized by its yellow pigmented, Gram negative bacillus bacteria, and lack of motility. 
Generally, Chryseobacterium are resistant to beta-lactams and carbapenems (Kim et al., 2020). 
This study’s results found DY, Chryseobacterium cucumeris, was resistant to 19 of the 24 
antibiotics and BY, Chryseobacterium ureilyticum, was resistant to 15 of the 24 antibiotics. Most 
of the resistance of these bacteria was from antibiotics in the beta-lactams and carbapenems 
classes. The bacteria in this genera are found in diverse habitats such as freshwater, soil, or dairy 
products. These species have also been identified as pathogens in untreated drinking water and 
some are opportunistic pathogens to animals (Dworkin et al., 2006). Therefore the high 
frequency in cooling towers, documented resistance to antibiotics, and pathogenic potential of 
Chryseobacterium sp. identifies a pathogen of concern that could cause disease outbreaks 




The bacteria designated CW was identified as Phenylobacterium sp. which is a small 
novel genera that can inhabit soil or aquatic habitats (Tiago et al., 2005). They are a Gram 
negative rod bacteria known to degrade herbicide, specifically chloridazon (Lingens et al., 1985). 
This bacterium also had similar antibiotic resistance to literature reports with resistance to 
ampicillin and carbenicillin (Aslam et al., 2005). However, being such a novel genera 
Phenylobacterium currently does not have any known pathogenic properties. The presence of a 
bacteria with antibiotic resistance genes but is not pathogenic is still of concern because it has the 
potential to pass that information on to another bacteria that may be pathogenic. This is 
especially concerning for cooling towers since they are hot spots for genetic exchange due to 
their environmental conditions (Fux et al., 2005; Hausner and Wuertz, 1999; Li et al., 2002; 
Molin and Tolker-Nielsen, 2003). 
Stenotrophomonas maltophilia was determined to be the identity of RY. This bacteria 
was a motile Gram negative bacillus with colonies that were smooth with a glistening yellow-
white color and entire margins (Denton and Kerr, 1998). They have been documented to grow in 
a number of aquatic habitats. Infections of S. maltophilia can cause respiratory issues and can be 
transmitted through fecal carriage on hands (Denton and Kerr, 1998). S. maltophilia is known to 
be resistant to a broad spectrum of antibiotics. There is conflicting data of S. maltophilia 
sensitivity to the carbapenem class. Denton and Kerr (1998) state S. maltophilia had particular 
resistance to carbapenems while Cullmann and Dick (1990) stated that S. maltophilia only 
occasionally had resistance to carbapenems. The strain found in this study showed susceptibility 
to the antibiotics in the carbapenem class and disagreed with Denton and Kerr (1998). However, 
this study did prove that S. maltophilia is resistant to a broad spectrum of antibiotics with 
resistance to 88% of the antibiotics tested, the highest antibiotic resistance of all the bacteria 
tested. Therefore, the presence of this bacteria posed serious concern for public health because S. 
maltophilia is frequently present in cooling towers, highly resistant to antibiotics, and causes 
respiratory illnesses. However, S. maltophilia are unlikely to survive in dry conditions, thus if 
aerosolized from a contaminated cooling tower S. maltophilia may die before causing infection 
(Hirai, 1991; Moffet et al., 1967; Rosenthal, 1974). 
Bacillus licheniformis was the identity of T, a Gram positive bacillus species that forms 




tower samples (Duc et al., 2003). It is considered non-pathogenic to humans and is often used in 
commercial settings for animal feeds (Cutting, 2011; de Boer et al., 1994). Its ability to form 
spores could allow it to evade sanitation events and persist in cooling towers (Bottone, 2010). B. 
licheniformis has resistance genes against erythromycin, chloramphenicol, streptomycin, but 
these genes are unlikely to be transferred horizontally (Agersø et al., 2019). B. licheniformis also 
has carbapenemases which make it resistant to carbapenems, which have the widest activity 
spectrum of the β-lactam group (Carfi et al., 1995; Halat and Moubareck, 2020; Queenan and 
Bush, 2007).  
B. licheniformis was resistant to 54% of the antibiotics in this study many of which were 
β-lactams, yet it was sensitive to the carbapenems of this group suggesting this strain did not 
contain genes for carbapenemases. Therefore, even though B. licheniformis had the highest 
bacteria presence and a 54% antibiotic resistance B. licheniformis does not pose a serious threat 
to cooling towers since this species is unlikely to transfer its resistance genes and is not 
considered pathogenic to humans (Agersø et al., 2019; de Boer et al., 1994).  
Finally, UK was determined to be Bacillus cereus, a spore forming Gram negative 
bacillus. As a spore B. cereus can be inactive and essentially protected from an adverse 
environment (Bottone, 2010). In a cooling tower environment a spore of B. cereus could be 
protected during sanitation events and persist in the tower afterwards. It can inhabit different 
aquatic environments, decaying organic matter, and invertebrate intestinal tracts (Berkeley et al., 
1984; Bottone, 2010). B. cereus is associated with food poisoning, respiratory tract infections, 
and nosocomial infections where HVAC systems could be bacterial reservoirs (Bottone, 2010; 
Bryce et al., 1993). B. cereus produce β-lactamases which renders them resistant to penicillins 
and cephalosporins (Bottone, 2010). They also produce carbapenemsases resulting in resistance 
to carbapenems (Carfi et al., 1995; Halat and Moubareck, 2020). It also has reported resistances 
to penicillin, ampicillin, cephalosporins, trimethoprim, erythromycin, oxacillin, and tetracycline 
(Bottone, 2010; Kiyomizu et al., 2008; National Committee for Clinical Laboratory Standards, 
1984; National Committee for Clinical Laboratory Standards, 1985; Savini et al., 2009; Turnbull 
et al., 2004). B. cereus is so resistant to broad-spectrum cephalosporins that the National 




should be avoided for suspected B. cereus infections (National Committee for Clinical 
Laboratory Standards, 1984; National Committee for Clinical Laboratory Standards, 1985).  
These reports of antibiotic sensitivity were consistent with the antibiotic resistance of B. 
cereus in this study however, this strain was susceptible to carbapenems suggesting it did not 
contain resistance genes for carbapenems. This was interesting, since B. cereus has been 
described with carbapenemases  (Carfi et al., 1995; Halat and Moubareck, 2020). The association 
with respiratory illnesses provides the potential for B. cereus to infect a wide range of people if 
released from cooling towers. The substantial amount of known antibiotic resistance of B. cereus 
makes infections of B. cereus difficult to treat. Finally, the ability to evade sanitation as a spore 
makes B. cereus a pathogen of concern in cooling towers since its release would pose a 
significant health risk. 
Chapter 6: EPG Evaluation Conclusion and Recommendations for Future Research 
In conclusion, the EPG devices were able to reduce bacterial CFUs to levels that are 
considered safe for cooling towers. Statistically one device did not perform better than the other 
in its ability to reduce the CFUs of bacteria present in the towers. However, the STD EPG was 
able to reduce CFUs slightly better than the EXP EPG. The bacterial diversity and antibiotic 
resistance between the two EPGs was also consistent. However, the STD EPG had a slightly 
lower species diversity and antibiotic resistance indicating it removed more diverse bacteria from 
the water. The STD EPG was able to reduce the presence of antibiotic resistant bacteria more 
effectively than the EXP EPG. The EXP EPG was able to more efficiently reduce Gram negative 
bacteria than the STD EPG. However, Gram stain did not indicate antibiotic resistance since 
there was an equal distribution of Gram positive and negative bacteria. The results of this study 
found that the STD EPG was able to reduce CFUs/ml and species diversity slightly more 
effectively than the EXP EPG. Therefore, the STD EPG was the superior EPG since it had an 
overall lower CFUs/ml, diversity, and abundance of antibiotic resistant bacteria. The bacteria this 
EPG allowed to persist had a lower potential to cause harm and were unlikely to produce 
biofilms as a result of the lower CFUs and cause fewer issues within the cooling tower.   
Based on these results there is heightened concern about the bacteria present in these 




deposited. The bacteria in the cooling towers was very diverse and it was unclear what factors 
influenced their growth. Each cooling tower had unique environmental factors that were likely 
affecting the bacterial growth. Seasonality significantly affected species diversity, while CFUs 
were constant. However, seasonality did affect the variation within bacteria loads, with more 
variation in summer than fall. Further examination should be performed to understand other 
factors that affection bacterial diversity and growth. The presence of highly antibiotic resistant 
bacteria suggests that cooling towers are hot spots for genetic exchange. Additionally, the EPGs 
used the same method as electroporation for gene transfer, thus further study should be 
performed to evaluate if EPGs are facilitating the transfer of antibiotic resistance genes. Finally, 
further testing should be performed to determine if one EPG device is more effective to reduce 







Appendix A: Antibiotic Zones of Inhibition 
Becton, Dickinson and Company Zones of Inhibition (Becton Dickinson and Company, 2011) 
*most resistant zones of inhibition are represented 












Amikacin AN 30 ≤14 15-16 ≥17 
Amoxicillin/ 
Clavulanic acid 
AmC 30 ≤13 14-19 ≥20 
Ampicillin AM 10 ≤13 14-28 ≥29 
Carbenicillin CB 100 ≤19 20-22 ≥29 
Cefazolin CZ 30 ≤14 15-17 ≥18 
Cefepime FEP 30 ≤ 21 22-23 ≥24 
Cefixime CFM 5 ≤15 16-17 ≥19 
Cefoxitin FOX 30 ≤24 25-26 ≥27 
Ceftriaxone CRO 30 ≤24 25-26 ≥27 
Cephalothin CF 30 ≤14 15-17 ≥18 
Ciprofloxacin CIP 5 ≤27 28-40 ≥41 
Doxycycline D 30 ≤12 13-15 ≥16 
Imipenem IPM 10 ≤13 14-15 ≥16 
Levofloxacin LVX 5 ≤13 14-16 ≥17 
Lomefloxacin LOM 10 ≤26 27-37 ≥38 
Meropenem MEM 10 ≤13 14-15 ≥16 
Mezlocillin MZ 75 ≤17 18-20 ≥21 
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Oxacillin OX 1 ≤17 - ≥18 
Piperacillin PIP 100 ≤17 18-20 ≥21 
Sulfadiazine SD 0.25 ≤10 11-14 ≥15 
Sulfamethoxazole/ 
Trimethoprim 
SXT ≤15 16-18 ≥19 
Ticracillin TIC 75 ≤14 15-19 ≥20 









Appendix B: Antibiotic chemical structures 
  
 
Ceftriaxone (Edgar181, 2007) 
 
 
Amikacin (Fvasconcellos, 2006) 
 
 
Levofloxacin (Derksen, 2007) 
 
 
Levofloxacin (Derksen, 2007) 
 
 
Ampicillin (Mysid, 2007) 
 
 
Amoxicillin/ Clavulanic acid (Fuse809, 2014) 
 
 




























Sulfamethoxazole/ Trimethoprim (Vaccinationist, 2015) 
 
 
Ciprofloxacin (Fvasconcellos, 2008) 
 
 
Mezlocillin (Jü, 2017) 
 
 




Lomefloxacin (Fvasconcellos, 2006) 
 
 
Carbenicillin (Fvasconcellos, 2006) 
 




   
 
Tobramycin (Fvasconcellos, 2008) 
 
Imipenem (Fvasconcellos, 2007) 
 
Cefalotin (GNU, 2008) 
 
Oxacillin (Fvasconcellos, 2007) 
 
Piperacillin (Fvasconcellos, 2008)  
Cefepime (Fuse809, 2014) 
 
Sulfadiazine (public domain) 
 




Appendix C: Tukey’s HSD on HPC Samplers Summer Sampling. *Bold indicates significant 
difference 
Difference of Sample Levels P-Value 
7/6/2020 Bld 14 - 7/21/2020 Bld 14 0 
7/6/2020 Bld 76 - 7/21/2020 Bld 14 0 
7/6/2020 Bld 14 - 7/21/2020 Bld 76 0 
7/6/2020 Bld 76 - 7/21/2020 Bld 76 0 
8/25/2020 Bld 14 - 7/6/2020 Bld 14 0 
8/25/2020 Bld 76 - 7/6/2020 Bld 14 0 
8/3/2020 Bld 14 - 7/6/2020 Bld 14 0 
8/3/2020 Bld 76 - 7/6/2020 Bld 14 0 
9/22/2020 Bld 14 - 7/6/2020 Bld 14 0 
9/22/2020 Bld 76 - 7/6/2020 Bld 14 0 
9/8/2020 Bld 14 - 7/6/2020 Bld 14 0 
9/8/2020 Bld 76 - 7/6/2020 Bld 14 0 
8/25/2020 Bld 14 - 7/6/2020 Bld 76 0 
8/25/2020 Bld 76 - 7/6/2020 Bld 76 0 
8/3/2020 Bld 14 - 7/6/2020 Bld 76 0 
8/3/2020 Bld 76 - 7/6/2020 Bld 76 0 
9/22/2020 Bld 14 - 7/6/2020 Bld 76 0 
9/22/2020 Bld 76 - 7/6/2020 Bld 76 0 
9/8/2020 Bld 14 - 7/6/2020 Bld 76 0 
9/8/2020 Bld 76 - 7/6/2020 Bld 76 0 
8/3/2020 Bld 76 - 7/21/2020 Bld 76 0.002 
8/25/2020 Bld 76 - 7/21/2020 Bld 76 0.011 
9/22/2020 Bld 76 - 7/21/2020 Bld 76 0.018 
9/8/2020 Bld 14 - 7/21/2020 Bld 76 0.018 
8/25/2020 Bld 14 - 7/21/2020 Bld 76 0.049 





Appendix C Continued 
Difference of Sample Levels P-Value 
9/22/2020 Bld 14 - 8/3/2020 Bld 76 0.096 
9/8/2020 Bld 76 - 7/21/2020 Bld 76 0.109 
8/3/2020 Bld 14 - 7/21/2020 Bld 76 0.22 
9/22/2020 Bld 14 - 8/25/2020 Bld 76 0.316 
9/22/2020 Bld 76 - 9/22/2020 Bld 14 0.402 
9/8/2020 Bld 14 - 9/22/2020 Bld 14 0.404 
9/22/2020 Bld 14 - 8/25/2020 Bld 14 0.639 
9/22/2020 Bld 14 - 7/21/2020 Bld 14 0.789 
9/8/2020 Bld 76 - 9/22/2020 Bld 14 0.829 
8/3/2020 Bld 76 - 8/3/2020 Bld 14 0.889 
9/22/2020 Bld 14 - 8/3/2020 Bld 14 0.947 
9/8/2020 Bld 76 - 8/3/2020 Bld 76 0.972 
9/22/2020 Bld 14 - 7/21/2020 Bld 76 0.979 
8/3/2020 Bld 76 - 7/21/2020 Bld 14 0.982 
8/3/2020 Bld 14 - 8/25/2020 Bld 76 0.994 
8/3/2020 Bld 76 - 8/25/2020 Bld 14 0.997 
9/22/2020 Bld 76 - 8/3/2020 Bld 14 0.998 
9/8/2020 Bld 14 - 8/3/2020 Bld 14 0.998 
8/25/2020 Bld 14 - 7/21/2020 Bld 14 1 
8/25/2020 Bld 76 - 7/21/2020 Bld 14 1 
8/3/2020 Bld 14 - 7/21/2020 Bld 14 1 
9/22/2020 Bld 76 - 7/21/2020 Bld 14 1 
9/8/2020 Bld 14 - 7/21/2020 Bld 14 1 
9/8/2020 Bld 76 - 7/21/2020 Bld 14 1 
7/6/2020 Bld 76 - 7/6/2020 Bld 14 1 
8/25/2020 Bld 76 - 8/25/2020 Bld 14 1 
8/3/2020 Bld 14 - 8/25/2020 Bld 14 1 




Appendix C Continued 
Difference of Sample Levels P-Value 
9/8/2020 Bld 14 - 8/25/2020 Bld 14 1 
9/8/2020 Bld 76 - 8/25/2020 Bld 14 1 
8/3/2020 Bld 76 - 8/25/2020 Bld 76 1 
9/22/2020 Bld 76 - 8/25/2020 Bld 76 1 
9/8/2020 Bld 14 - 8/25/2020 Bld 76 1 
9/8/2020 Bld 76 - 8/25/2020 Bld 76 1 
9/8/2020 Bld 76 - 8/3/2020 Bld 14 1 
9/22/2020 Bld 76 - 8/3/2020 Bld 76 1 
9/8/2020 Bld 14 - 8/3/2020 Bld 76 1 
9/8/2020 Bld 14 - 9/22/2020 Bld 76 1 
9/8/2020 Bld 76 - 9/22/2020 Bld 76 1 






Appendix D: Bacteria Physical Descriptions 
Designation Description 
3W Beige/white translucent colony color, entire margin, 3 mm 
A 
White colony color, undulating edge with rings, flat with a raised center, 10 
mm 
AP 
Aggregates of yellow translucent pinhead-like colonies that resulted in an 
appearance of a dark yellow center and lighter edges in a gradient, 5 mm 
B White colony color, raised edge with sunken middle, 2 mm 
BB Blue/white colony color, irregular margin, 3mm 
BBW Beige colony color, flat, entire, 3-5mm 
BC 
White colony color, circular edge, ringed, outer ring has a gradient to the 
edge, center solid with irregular bumps and dotted texture 
BW flat, white, 3-5 mm 
BY Big yellow colonies, entire, convex, 5 mm 
C White undulating bullseye, white gradient, dips into agar, 10 mm 
CB Beige, convex, 1 mm, opaque 
CW White, convex, entire, 1-4 mm 
CY Light yellow, highly convex with a height of 1 mm, entire margin, 1-10 mm 
DLY 
Light yellow, entire, convex, divot in center, like dy but lighter and without 
lines, 4 mm 
DW 
Opaque white irregular edge, wrinkly texture that grows upward, 2-3 mm up 





Appendix D Continued 
DY 
Yellow, slight indent at center, entire, lines in the center that resemble an iris, 
4mm 
EGG 
Circular white center with translucent outer edge that undulates, looks like a 
fried egg 
F White frosty colored, flat, 4-10 mm 
FB Murky white, flat, undulating, bullseye, flat, edge dry looking, 15 mm 
FW White, flat, 2 mm, entire, so flat looks level with the agar ring around edge 
FY Yellow, irregular edge, flat, uneven texture (like fruit leather), radial gradient 
G Greenish (yellow/blue), lowly convex, entire 1-4 mm 
GB Translucent green with a brown like inside, undulating edge 
GK 
White translucent, irregular edge, textured with a bumpy appearance like 
after pulling off a sticker with a gradient edge, middle is sunken edge is 
raised, irregular edge that is mostly entire with some undulations, 10-20 mm 
H 
Yellow, transparent/clear edge, yellow center and predominant color, can 
grow in/on other colonies, 1-2 mm 
IB Beige, flat top, raised, entire edge, iridescent lines on top, 8 mm 
IG iridescent green 
IRB Beige, irregular edge, flat uneven texture, 7 mm 
IW White, irregular edge, wrinkly, 4 mm 
IWA 
White color, translucent light white irregular edge boundary, then a solid 






Appendix D Continued 
IY 
Yellow beige, convex mostly entire, with some undulating and some 
iridescence in the center  
J Transparent/clear, elevated, bumps like warts irregularly placed on top, 5 mm 
K 
Beige, translucent, flat, textured with a bumpy appearance like after pulling 
off a sticker, irregular edge that is mostly entire with some undulations, 10-
20 mm 
L White/beige, opaque, circular, fuzzy edge, ring pattern in center, 30 mm 
LO Opaque light orange, flat, 5 mm 
LW 
White, entire, raised 1 mm above agar, slight indent in center, slightly 
wrinkled texture on surface, 4 mm 
LY Light yellow, raised, 1-5 mm 
LYB Yellow, raised ~1 mm, divot in center, 2 mm 
M 
White, with a white opaque circular center, undulating textured edges in an 
oblong shape 
N Orange, flat, dry appearance, raise lip around edge, 12 mm 
O Orange, convex, <1 mm 
P Pinhead, translucent, <1 mm 
PO Pinhead orange, entire, <1 mm 
PR Pinhead red, entire, <1 mm 
PY Yellow pinhead, entire, <1 mm 






Appendix D Continued 
RC Red, entire, flat, 1.5 mm 
RK 
Beige, translucent, flat, textured with a bumpy appearance like after pulling 
off a sticker, smooth textured undulating ring around the edge, 10-20 mm 
RT Red, translucent, entire, 1 mm 
RU 
White colony, undulating center with an undulating ring around it, flat, 13 
mm 
RW White opaque, raised but with a flat top, entire, 3 mm 
RWA 
White colony with a wormy/brain texture and elevated ring around inner and 
undulates, 8 mm  
RY Ringed yellow/white, raised, convex, entire, 2-5 mm 
T Transparent, flat, 1 mm 
TB Translucent yellow/brown, irregular edge, 3 mm, flat 
TP Translucent pink, entire, 1 mm 
TU 
Transparent beige color, undulating edge, flat, textured like the “Sally 
Hansen Fuzzy Coat Textured Nail Color” with short rods in the colony, 
40mm 
TW Transparent, wrinkly, irregular edge, 3 mm 
TY Translucent yellow, uneven circular edge  
U Beige, undulating, 32 mm 
UB White, undulating with a bullseye, raised, 10 mm 
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UK 
Translucent white/beige, flat undulating edge, textured with a bumpy 
appearance like after pulling off a sticker, smooth textured undulating ring 
around the edge, 24 mm 
UT Translucent, white middle, undulating edge 
UW White, undulating, flat, 8 mm 
UY Yellow, raised, irregular edge almost circular 
VY Yellow, highly convex, entire, 2mm 
W White, opaque, 1 mm 
WA 
White, circular (not entire but almost) wiggly wormy/ brain like texture, flat, 
11mm 
WB Beige, wrinkly, entire, bullseye rings colony formation 
WC White, wrinkly/ undulating edge 
WP Light pink color, ring texture, 2 mm 
WW 
White/opaque beige outer, solid white fuzzy inner, solid grey fuzzy center, 
convex, 1 mm 
WY White-yellow, raised with a flat top, 1-4 mm 
Y Yellow, opaque, raised, 1mm 
YB Yellow, entire with elevated rings (raised edge with sunken middle) 






Appendix E: Gram Stain Results of Isolated Bacteria from Cooling Tower Samples 
Designation Gram Stain  Bacteria 
Shape 
Notes 
3W Negative  bacillus   
A Negative bacillus in spindly rows 
AP Negative coccus   
B Positive bacillus small and 
clustered 
BB Negative bacillus   
BBW Negative bacillus   
BC Positive bacillus   
BW Positive coccus   
BY Negative bacillus   
C Negative bacillus   
CB Negative bacillus   
CW Positive coccus   
CY Negative bacillus in clumps 
DLY Negative coccus   
DW Negative coccus   
DY Negative bacillus   
EGG Positive coccus in strings 
F Positive bacillus   
FB Positive bacillus in lines  
FW Positive bacillus   
FY Negative bacillus   





Appendix E Continued 
GB Unable to isolate to gram stain     
GK Positive bacillus in lines/ fibrous 
H Negative bacillus   
IB Positive bacillus   
IG Negative bacillus   
IRB Negative bacillus   
IW Positive bacillus   
IWA Positive bacillus   
IY Positive bacillus   
J Positive coccus   
K Positive coccus   
L Positive bacillus   
LO Positive coccus   
LW Positive coccus   
LY Negative bacillus small bacillus 
LYB Negative bacillus   
M Negative coccus   
N Unable to isolate to gram stain     
O Negative bacillus   
P Negative coccus   
PO Unable to isolate to gram stain     
PR Unable to isolate to gram stain     
PY Negative bacillus   
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RC Negative coccus   
RK Positive bacillus   
RT Negative coccus in clusters 
RU Negative coccus   
RW Positive coccus   
RWA Negative bacillus   
RY Negative bacillus   
T Negative bacillus   
TB Positive coccus   
TP Unable to isolate to gram stain     
TU Negative coccus   
TW Negative bacillus   
TY Negative bacillus   
U Positive bacillus   
UB Positive coccus diplococci 
UF Negative bacillus   
UK Positive bacillus   
UT Negative bacillus   
UW Positive coccus   
UY Negative bacillus   
VY Negative bacillus   
W Negative coccus   
WA Positive coccus   
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WC Positive coccus   
WP Positive bacillus   
WW Positive coccus   
WY Negative bacillus   
Y Negative bacillus   
YB Negative bacillus   






Appendix F: Gram Stains and Bacteria Morphology of Bacteria Sequenced for their 16S rRNA 
Gene 
 
Figure S- 1: Gram stain of BW, Morganella morganii  
 





Figure S- 3: Gram stain of BY, Chryseobacterium ureilyticum 
 






Figure S- 5: Gram stain of CW, Phenylobacterium sp. 
 





Figure S- 7: Gram stain of DY, Chryseobacterium cucumeris 
 





Figure S- 9: Gram stain of RY Stenotrophomonas maltophilia 
 





Figure S- 11: Gram stain of T, Bacillus licheniformis 
 





Figure S- 13: Gram stain of UK, Bacillus cereus 
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